Pulmonary Disease, Chronic Obstructive Clinical Trials

23 recruiting

Pulmonary Disease, Chronic Obstructive Trials at a Glance

27 actively recruiting trials for pulmonary disease, chronic obstructive are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in London, Hamburg, and Bucharest. Lead sponsors running pulmonary disease, chronic obstructive studies include GlaxoSmithKline, Foundation University Islamabad, and Acibadem University.

Browse pulmonary disease, chronic obstructive trials by phase

Treatments under study

About Pulmonary Disease, Chronic Obstructive Clinical Trials

Looking for clinical trials for Pulmonary Disease, Chronic Obstructive? There are currently 23 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pulmonary Disease, Chronic Obstructive trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pulmonary Disease, Chronic Obstructive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 27 trials

Recruiting

Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

Pulmonary Disease, Chronic Obstructive
AstraZeneca2,000 enrolled7 locationsNCT06712563
Recruiting

Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations

Pulmonary Disease, Chronic ObstructiveExacerbation Copd
University Hospital, Grenoble240 enrolled2 locationsNCT05704881
Recruiting
Not Applicable

Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive (COPD)
Foundation University Islamabad40 enrolled1 locationNCT07518472
Recruiting
Phase 3

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline960 enrolled159 locationsNCT06961214
Recruiting
Not Applicable

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Pulmonary Disease, Chronic Obstructive
Seattle Institute for Biomedical and Clinical Research4,000 enrolled5 locationsNCT05718102
Recruiting
Phase 3

Trial to Determine Effective Aspirin Dose in COPD

Pulmonary Disease, Chronic Obstructive
Johns Hopkins University48 enrolled1 locationNCT05265299
Recruiting

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Heart FailureCoronary Artery DiseaseOral Microbiota+9 more
Danderyd Hospital1,400 enrolled1 locationNCT07476703
Recruiting
Phase 2

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.195 enrolled29 locationsNCT07252908
Recruiting
Phase 3

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline1,196 enrolled6 locationsNCT07177339
Recruiting
Phase 3

Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive (COPD)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.594 enrolled4 locationsNCT07039669
Recruiting
Phase 3

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline981 enrolled15 locationsNCT06959095
Recruiting
Not Applicable

Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease

Pulmonary Disease, Chronic Obstructive (COPD)
Foundation University Islamabad46 enrolled1 locationNCT07177976
Recruiting
Phase 1

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline130 enrolled32 locationsNCT06154837
Recruiting

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Heart FailureAsthmaDepressive Disorder+13 more
Universitätsklinikum Hamburg-Eppendorf240 enrolled1 locationNCT06890208
Recruiting
Not Applicable

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

Heart FailureBreast NeoplasmsObesity+10 more
Universitätsklinikum Hamburg-Eppendorf660 enrolled1 locationNCT06831994
Recruiting
Not Applicable

The Effect of Gait Training Using Different Slope Types on Balance in COPD Patients

Pulmonary Disease, Chronic Obstructive
Acibadem University51 enrolled1 locationNCT06644898
Recruiting
Not Applicable

Investigation of Walking Training With Different Slope Types in COPD Patients

Pulmonary Disease, Chronic Obstructive
Acibadem University51 enrolled1 locationNCT06283004
Recruiting

The ROAM Research Study Therapy (LTOT) Version

Pulmonary Disease, Chronic Obstructive
University of Virginia100 enrolled1 locationNCT06810323
Recruiting
Not Applicable

Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)

Pulmonary Disease, Chronic Obstructive
Maastricht University Medical Center166 enrolled1 locationNCT03807310
Recruiting
Not Applicable

Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home

Pulmonary Disease, Chronic Obstructive
Necmettin Erbakan University74 enrolled1 locationNCT05730088